Palovarotene dose level 1 ( DrugBank: Palovarotene )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
272	進行性骨化性線維異形成症	1

272. 進行性骨化性線維異形成症

臨床試験数 : 39 / 薬物数 : 38 - (DrugBank : 7) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 95

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02279095 (ClinicalTrials.gov)	October 27, 2014	26/10/2014	An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FO ...	A Phase 2, Open-Label Extension, Efficacy and Safety Study of a Retinoic Acid Receptor Gamma (RAR?) ...	Fibrodysplasia Ossificans Progressiva	Drug: Palovarotene dose level 1;Drug: Palovarotene dose level 2;Drug: Palovarotene dose level 3;Drug ...	Clementia Pharmaceuticals Inc.	NULL	Completed	6 Years	65 Years	All	54	Phase 2	United States;Argentina;Australia;France;United Kingdom

First Previous1Next Last